EPO Use OK In All But Eight Cancer Conditions, Medicare NCD Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Final National Coverage Determination issued July 30 drops number of restricted uses of erythropoiesis-stimulating agents from the 13 listed in the draft NCD.